QQQ   415.91 (-1.77%)
AAPL   164.21 (-1.69%)
MSFT   398.88 (-1.33%)
META   483.13 (-3.72%)
GOOGL   153.17 (-1.82%)
AMZN   174.75 (-2.49%)
TSLA   148.59 (-0.89%)
NVDA   808.23 (-4.54%)
AMD   148.30 (-4.37%)
NIO   3.81 (-4.75%)
BABA   68.50 (-0.55%)
T   16.32 (-0.06%)
F   12.10 (+0.33%)
MU   106.98 (-4.42%)
GE   148.32 (-3.02%)
CGC   7.94 (+1.40%)
DIS   111.40 (-0.92%)
AMC   3.22 (+10.27%)
PFE   25.80 (+1.61%)
PYPL   61.81 (-0.47%)
XOM   119.97 (+1.22%)
QQQ   415.91 (-1.77%)
AAPL   164.21 (-1.69%)
MSFT   398.88 (-1.33%)
META   483.13 (-3.72%)
GOOGL   153.17 (-1.82%)
AMZN   174.75 (-2.49%)
TSLA   148.59 (-0.89%)
NVDA   808.23 (-4.54%)
AMD   148.30 (-4.37%)
NIO   3.81 (-4.75%)
BABA   68.50 (-0.55%)
T   16.32 (-0.06%)
F   12.10 (+0.33%)
MU   106.98 (-4.42%)
GE   148.32 (-3.02%)
CGC   7.94 (+1.40%)
DIS   111.40 (-0.92%)
AMC   3.22 (+10.27%)
PFE   25.80 (+1.61%)
PYPL   61.81 (-0.47%)
XOM   119.97 (+1.22%)
QQQ   415.91 (-1.77%)
AAPL   164.21 (-1.69%)
MSFT   398.88 (-1.33%)
META   483.13 (-3.72%)
GOOGL   153.17 (-1.82%)
AMZN   174.75 (-2.49%)
TSLA   148.59 (-0.89%)
NVDA   808.23 (-4.54%)
AMD   148.30 (-4.37%)
NIO   3.81 (-4.75%)
BABA   68.50 (-0.55%)
T   16.32 (-0.06%)
F   12.10 (+0.33%)
MU   106.98 (-4.42%)
GE   148.32 (-3.02%)
CGC   7.94 (+1.40%)
DIS   111.40 (-0.92%)
AMC   3.22 (+10.27%)
PFE   25.80 (+1.61%)
PYPL   61.81 (-0.47%)
XOM   119.97 (+1.22%)
QQQ   415.91 (-1.77%)
AAPL   164.21 (-1.69%)
MSFT   398.88 (-1.33%)
META   483.13 (-3.72%)
GOOGL   153.17 (-1.82%)
AMZN   174.75 (-2.49%)
TSLA   148.59 (-0.89%)
NVDA   808.23 (-4.54%)
AMD   148.30 (-4.37%)
NIO   3.81 (-4.75%)
BABA   68.50 (-0.55%)
T   16.32 (-0.06%)
F   12.10 (+0.33%)
MU   106.98 (-4.42%)
GE   148.32 (-3.02%)
CGC   7.94 (+1.40%)
DIS   111.40 (-0.92%)
AMC   3.22 (+10.27%)
PFE   25.80 (+1.61%)
PYPL   61.81 (-0.47%)
XOM   119.97 (+1.22%)
NASDAQ:TRUP

Trupanion (TRUP) Stock Price, News & Analysis

$22.02
+0.66 (+3.09%)
(As of 12:21 PM ET)
Today's Range
$21.36
$22.38
50-Day Range
$21.36
$35.28
52-Week Range
$18.45
$37.71
Volume
380,269 shs
Average Volume
674,934 shs
Market Capitalization
$920.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$33.20

Trupanion MarketRank™ Stock Analysis

Analyst Rating
Hold
2.25 Rating Score
Upside/​Downside
50.8% Upside
$33.20 Price Target
Short Interest
Bearish
40.35% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.61
Upright™ Environmental Score
News Sentiment
0.53mentions of Trupanion in the last 14 days
Based on 12 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.43) to $0.05 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.22 out of 5 stars

Finance Sector

605th out of 845 stocks

Hospital & Medical Service Plans Industry

8th out of 11 stocks

TRUP stock logo

About Trupanion Stock (NASDAQ:TRUP)

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.

TRUP Stock Price History

TRUP Stock News Headlines

The Best AI Stock to Own in the World Today is Trading for Just $25
“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.
Trupanion Inc
Dog bless you
Analyzing NeueHealth (NYSE:NEUE) & Trupanion (NASDAQ:TRUP)
The Best AI Stock to Own in the World Today is Trading for Just $25
“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.
Trupanion Publishes 2023 Annual Letter to Shareholders
Texas pets are feeling allergy season
Trupanion, Inc.'s (NASDAQ:TRUP) Path To Profitability
Piper Sandler Reaffirms Their Hold Rating on Trupanion (TRUP)
Spring allergies suck for pets, too
More scratchy, sniffly pets
Pet allergies on the uptick
Dog allergy reports are up
See More Headlines
Receive TRUP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trupanion and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/15/2024
Today
4/19/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Hospital & medical service plans
Sub-Industry
N/A
Current Symbol
NASDAQ:TRUP
Employees
1,142
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$33.20
High Stock Price Target
$47.00
Low Stock Price Target
$28.00
Potential Upside/Downside
+55.4%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

Net Income
$-44,690,000.00
Pretax Margin
-4.06%

Debt

Sales & Book Value

Annual Sales
$1.11 billion
Book Value
$7.31 per share

Miscellaneous

Free Float
39,386,000
Market Cap
$893.06 million
Optionable
Optionable
Beta
1.71
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. Darryl Graham Andrew Rawlings (Age 55)
    Founder, CEO & Chair of the Board
    Comp: $300k
  • Ms. Margaret Rosemary Maria Tooth (Age 45)
    President
    Comp: $300k
  • Ms. Emily Dreyer (Age 36)
    Senior Vice President of Channel Growth
    Comp: $261.87k
  • Mr. Fawwad Qureshi
    Chief Finance Officer
  • Ms. Brenna McGibney (Age 55)
    Chief Administrative Officer
  • Ms. Laura Bainbridge
    Senior Vice President of Corporate Communications
  • Dr. Steve Weinrauch BVMS (Age 49)
    MRCVS, Executive Vice President of North America & Veterinary Strategy
  • Ms. Bradley Lamb
    Head of Conversion
  • Mr. John Gallagher (Age 37)
    Executive Vice President of Global Support Services
  • Mr. Shawn McWashington
    Head of Corporate Group Benefits

TRUP Stock Analysis - Frequently Asked Questions

Should I buy or sell Trupanion stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trupanion in the last twelve months. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" TRUP shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TRUP, but not buy additional shares or sell existing shares.
View TRUP analyst ratings
or view top-rated stocks.

What is Trupanion's stock price target for 2024?

4 Wall Street analysts have issued 12 month price targets for Trupanion's stock. Their TRUP share price targets range from $28.00 to $47.00. On average, they anticipate the company's stock price to reach $33.20 in the next twelve months. This suggests a possible upside of 50.8% from the stock's current price.
View analysts price targets for TRUP
or view top-rated stocks among Wall Street analysts.

How have TRUP shares performed in 2024?

Trupanion's stock was trading at $30.51 at the beginning of the year. Since then, TRUP shares have decreased by 27.8% and is now trading at $22.02.
View the best growth stocks for 2024 here
.

When is Trupanion's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our TRUP earnings forecast
.

How were Trupanion's earnings last quarter?

Trupanion, Inc. (NASDAQ:TRUP) released its quarterly earnings data on Thursday, February, 15th. The financial services provider reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.18) by $0.13. The financial services provider had revenue of $295.50 million for the quarter, compared to analysts' expectations of $289.84 million. Trupanion had a negative net margin of 4.03% and a negative trailing twelve-month return on equity of 15.19%. The firm's revenue for the quarter was up 20.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.23) earnings per share.

What ETFs hold Trupanion's stock?

ETFs with the largest weight of Trupanion (NASDAQ:TRUP) stock in their portfolio include ProShares Pet Care ETF (PAWZ) and iShares U.S. Insurance ETF (IAK).Noble Absolute Return ETF (NOPE).

What guidance has Trupanion issued on next quarter's earnings?

Trupanion updated its FY 2024 earnings guidance on Friday, February, 16th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.2 billion-$1.3 billion, compared to the consensus revenue estimate of $1.2 billion.

What is Darryl Rawlings' approval rating as Trupanion's CEO?

139 employees have rated Trupanion Chief Executive Officer Darryl Rawlings on Glassdoor.com. Darryl Rawlings has an approval rating of 76% among the company's employees.

What other stocks do shareholders of Trupanion own?
How do I buy shares of Trupanion?

Shares of TRUP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TRUP) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners